SANUWAVE Health (SNWV) Stock Price, News & Analysis

Company Overview

SANUWAVE Health, Inc. is a medical technology company focused on the development and commercialization of non‐invasive, extracorporeal shockwave therapy devices. Headquartered in Suwanee, Georgia, the company designs and markets its proprietary Pulse® technology platform, which delivers acoustic shockwaves to stimulate tissue regeneration and repair. SANUWAVE’s primary objective is to address chronic and hard-to-heal conditions across wound care and musculoskeletal indications by offering an alternative to surgical intervention.

The company’s flagship product, the PACE® (Pulse Activated Cell therapy) system, is intended for the treatment of diabetic foot ulcers and other types of chronic wounds. By using low- to medium-intensity acoustic pulses, PACE therapy is designed to promote cellular activity, increase local circulation and accelerate the natural healing process. SANUWAVE also explores applications of its Pulse technology in orthopedics, sports medicine and veterinary medicine, conducting pilot studies and clinical protocols to broaden the device’s therapeutic scope.

SANUWAVE has pursued regulatory clearances including U.S. Food and Drug Administration (FDA) approvals and CE marking for European markets. The company works with a network of specialized distributors and clinical partners across North America, Europe and Asia to facilitate product adoption in hospitals, outpatient clinics and wound care centers. SANUWAVE continues to invest in research and development, aiming to expand its clinical evidence base and secure additional indications that leverage its shockwave therapy platform.

Key Stats

• Today's Range: $34.00 to $36.67
• 50-Day Range: $33.27 to $45.00
• 52-Week Range: $5.63 to $46.58
• Volume: 35,394 shs
• Average Volume: 50,780 shs
• Market Capitalization: $292.17 million
• P/E Ratio: 4.10
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SNWV Stock Analysis - Frequently Asked Questions

How have SNWV shares performed this year?

SANUWAVE Health's stock was trading at $23.00 at the beginning of the year. Since then, SNWV stock has increased by 48.3% and is now trading at $34.10.

How were SANUWAVE Health's earnings last quarter?

SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its quarterly earnings results on Monday, November, 16th. The company reported ($7.50) EPS for the quarter, missing the consensus estimate of ($3.75) by $3.75. The company earned $1.97 million during the quarter. SANUWAVE Health had a negative net margin of 1.33% and a negative trailing twelve-month return on equity of 23.83%.

When did SANUWAVE Health's stock split?

SANUWAVE Health's stock reverse split on the morning of Friday, October 18th 2024.The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

How do I buy shares of SANUWAVE Health?

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SANUWAVE Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SANUWAVE Health investors own include Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV).

Company Calendar

• Last Earnings: 11/16/2020
• Today: 9/16/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:SNWV
• CIK: 1417663
• Web: www.sanuwave.com
• Phone: (770) 419-7525
• Fax: 770-419-8634
• Employees: 40
• Year Founded: 2005

Profitability

• EPS (Trailing Twelve Months): ($8.25)
• Trailing P/E Ratio: 4.10
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.81 million
• Net Margins: -1.33%
• Pretax Margin: -1.31%
• Return on Equity: -23.83%
• Return on Assets: -20.60%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.12
• Quick Ratio: 0.08

Sales & Book Value

• Annual Sales: $39.19 million
• Price / Sales: 7.45
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($14.02) per share
• Price / Book: -2.43

Miscellaneous

• Outstanding Shares: 8,568,000
• Free Float: 5,418,000
• Market Cap: $292.17 million
• Optionable: Not Optionable
• Beta: 1.39